MIMS2 and neoplasm: We hypothesized that FAM210B may also influence tumor progression in vivo; we therefore established a xenograft tumor model via the subcutaneous injection of Hep3B cells stably overexpressing the FAM210B sequence (Lenti-FAM210B) or empty lentivector (Lentivector) into the dorsal flank of nude mice.